ARCA biopharma, Inc.
8001 Arista Place
Suite 200
Broomfield,
CO 80021
United States - Map
Phone: 720-940-2200
Fax: 720-208-9261
Web Site: http://www.arcadiscovery.com
| ARCA biopharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States. The companys lead product candidate includes Gencaro, a pharmacologically beta-blocker and mild vasodilator for the treatment of chronic heart failure and other indications. It also focuses on the development of NU172, a short-acting anticoagulant used during medical or surgical procedures, which has completed Phase Ib clinical study. ARCA biopharma has a collaboration agreement with LabCorp to develop the Gencaro Test, a companion test for the genetic markers that predict clinical response to Gencaro. The company is headquartered in Broomfield, Colorado. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Richard B. Brewer , 56
Chairman |
N/A
| N/A | Mr. Michael Bristow M.D., Ph.D., 64
Founder, Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Christopher D. Ozeroff , 50
Co-Founder, Exec. VP of Bus. Devel., Sec. and Gen. Counsel |
N/A
| N/A | Ms. Kathryn E. Falberg , 48
Chief Financial Officer and Chief Operating Officer |
N/A
| N/A | Mr. Derek Cole ,
VP of Investor Relations and Corp. Communications |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
